No Vacillation on HPV Vaccination
Copyright policy )No Vacillation on HPV Vaccination
Evidence of the safety and protective benefits of human papillomavirus virus (HPV) vaccines as an anti-cancer measure is overwhelming. However, vaccine uptake varies widely across countries and falls short of levels needed to achieve population immunity. We highlight policy measures that would help ensure greater worldwide coverage and save lives.
- University of Queensland Australia
- University of Sydney Australia
- Centenary Institute of Cancer Medicine and Cell Biology Australia
- Translational Research Institute Australia
- RIKEN Center for Biosystems Dynamics Research Japan
1300 Biochemistry, Papillomavirus Infections, Vaccination, Uterine Cervical Neoplasms, Genetics and Molecular Biology, Alphapapillomavirus, Global Health, Crisis, Japan, 1300 Biochemistry, Genetics and Molecular Biology, Humans, Female, Papillomavirus Vaccines
1300 Biochemistry, Papillomavirus Infections, Vaccination, Uterine Cervical Neoplasms, Genetics and Molecular Biology, Alphapapillomavirus, Global Health, Crisis, Japan, 1300 Biochemistry, Genetics and Molecular Biology, Humans, Female, Papillomavirus Vaccines
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).25 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Top 10% influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Top 10% impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 10%
Citations provided by BIP!Popularity provided by BIP!